Issuer

PT. Asuransi Harta Aman Pratama Tbk

Issuer Code

AHAP

Number of shares offered

1,960,000,000 shares

Ratio (previous stock:new stock)

3:2

Nominal Value

Rp 50 per share

Exercise Price

 Rp 50

Dilution (if shareholders do not exercise their rights)

 Max. 40%

Plan of proceeds usage

The purpose of PMHMETD IV is to strengthen capital in order to maintain financial health ratios in accordance with the requirements determined by applicable regulations.

1. Proceeds from PMHMETD IV, after deducting all costs associated with PMHMETD IV, will be used entirely for working capital by adding to the investment portfolio to increase the capability of owned retention, which is expected to increase the absorb capacity for any risks incurred, and further increase the amount of net premium received. The addition of an investment portfolio will increase the Solvency Ratio or Risk Based Capital (RBC) and Investment Adequacy Ratio (RKI) in order to support the company's business growth. These funds will be placed in investment instruments such as deposits, bonds, stocks and others with due observance of POJK No.71/POJK.05/2016, POJK No. 27/POJK.05/2018, POJK No. 17/POJK.04/2020 and/or POJK No. 42/POJK.04/2020.

Extraordinary General Meeting of Shareholders (EGMS)

April 14, 2022

Effective Date

July 19, 2022

Cum Date in Regular and Negotiated Markets

July 27, 2022

Ex Date in Regular and Negotiated Markets

July 28, 2022

Cum Date in Cash Market

July 29, 2022

Ex Date in Cash Market

August 1, 2022

Recording Date

July 29, 2022

Distribution Date

August 1, 2022

Listing Date

August 2, 2022

Trading Period of Rights issue

August 2 - 8, 2022

Distribution Period of rights issue

August 4 - 10, 2022

Last Payment Date of Additional Share Orders

August 10, 2022

Allotment Date

August 11, 2022

Refund date of excess money purchase of Additional Shares

August 12, 2022